AZRX AzurRx BioPharma, Inc.

-0.01  -0%
Previous Close 3.75
Open 3.72
Price To book 11.23
Market Cap 36.02M
Shares 9,631,000
Volume 14,795
Short Ratio 0.50
Av. Daily Volume 22,128

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Announced December 21, 2016 that Phase 2 enrollment has commenced. Trial completion due 3Q 2017.
Exocrine pancreatic insufficiency (EPI) caused by chronic pancreatitis (CP)